Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse

Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse

Abstract The potential of dendritic cell (DC) vaccination against cancer is not fully achieved. Little is known about the precise nature of the anti-cancer immune response triggered by different natural DC subsets and their relevance in preventing postsurgical tumor recurrence. Here, we use mouse sp...

Full description

Saved in:
Bibliographic Details
Main Authors: Ignacio Heras-Murillo, Diego Mañanes, Pablo Munné, Vanessa Núñez, Jessica Herrera, Mauro Catalá-Montoro, Maite Alvarez, Miguel A. del Pozo, Ignacio Melero, Stefanie K. Wculek, David Sancho
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-58289-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41467-025-58289-1

Similar Items